Affect Therapeutics
Using mobile technology to deliver the world's first evidence-based, substance-specific recovery program for methamphetamine and cocaine use disorder. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD87—131m (Dealroom.co estimates Jul 2023.)
Remote Oregon (HQ)
Authorizing premium user...